Palatin Technologies
PTN
#10124
Rank
C$44.47 M
Marketcap
C$25.10
Share price
1.75%
Change (1 day)
3,905.83%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -C$6.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$8.84 Million. In 2024 the company made an earning of -C$37.5 Million, an increase over its 2023 earnings that were of -C$45.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$6.94 Million-81.51%
2024 -C$37.5 Million-16.9%
2023 -C$45.12 Million5.99%
2022 -C$42.58 Million-13.7%
2021 -C$49.33 Million33.25%
2020 -C$37.02 Million-172.11%
2019 C$51.33 M2352.33%
2018 C$2.09 M-94.13%
2017 C$35.67 M-154.92%
2016 -C$64.95 Million3.67%
2015 -C$62.65 Million878%
2014 -C$6.41 Million-72.64%
2013 -C$23.42 Million-33.11%
2012 -C$35.01 Million77.71%
2011 -C$19.7 Million
2003 -C$33.36 Million29.93%
2002 -C$25.67 Million36.18%
2001 -C$18.85 Million
1999 -C$15.65 Million6.04%
1998 -C$14.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.69 B-699,817.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$19.63 B-294,318.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$0.88 B-13,374.02%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.71 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.22 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$70.35 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$41.04 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$77.32 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA